In all likelihood, FY19 is going to be a milestone year for Goldman Sachs-backed medical device manufacturer BPL Medical Technologies.
The Bengaluru-based company, in which the Nambiar family still holds around 35 per cent stake, is expecting to break even this year.
The firm is also zeroing in on another global acquisition as it targets to cross Rs 1,000 crore in revenue by 2022, managing director and chief executive officer Sunil Khurana told Business Standard.
Khurana, a veteran in the healthcare space who had spent almost 28 years in GE Healthcare, joined BPL Medical Technologies in August 2013 immediately after